
Vynleads, Inc.
93
Recent news highlights Vynleads' launch of the Done With Diabetes app featuring AI-powered daily lifestyle support and the unveiling of the broader Done With Lifestyle Blueprint technology platform.
- Vynleads launched the Done With Diabetes app, providing AI-powered daily lifestyle support for blood sugar and metabolic health [N1].
- The company unveiled the Done With Lifestyle Blueprint technology platform and prepared for app launch, emphasizing AI-enabled coaching and personalization [N2].
Vynleads, Inc. operates as a wellness technology company specializing in metabolic health and chronic lifestyle-influenced conditions. Its primary product is the Done With Diabetes app, an eight-week structured program delivered via a digital platform that integrates AI-enabled coaching and personalization. The app guides users through a 56-day Success Blueprint with phases focused on education, habit formation, and accountability, supported by AI workflows and community features. The company is shifting from one-time digital wellness products to a recurring subscription platform priced at $29 per month after a free trial. Vynleads aims to expand its platform to enterprise customers such as employers and health plans, offering scalable lifestyle programs with AI-driven personalization. The platform architecture is cloud-based, supporting user management, program engagement, AI chat, and reporting. The company holds proprietary rights to its brands and technology and operates under various regulatory frameworks related to consumer protection, privacy, and AI governance. As of mid-2026, Vynleads had one employee and relies on third-party partners for operations.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Vynleads, Inc. is a wellness technology company focused on metabolic health, delivering its flagship Done With Diabetes app as a subscription-based, AI-enabled lifestyle wellness platform. The company is transitioning from discrete digital products to a scalable, recurring platform model emphasizing AI and agentic workflows. As of June 30, 2026, the company reported no revenue and a net loss, with limited liquidity and a low current ratio, reflecting early-stage investment and operational scale. The company competes in a highly competitive market and is subject to regulatory and operational risks inherent in digital health and AI-enabled wellness services.
The company's transition to a recurring subscription model with AI-enabled and agentic support workflows could enhance scalability and personalization, potentially improving user engagement and retention. The platform's design for daily use and ongoing maintenance mode may foster sustained customer relationships. Expansion into enterprise distribution channels could diversify revenue streams and increase market reach. Proprietary technology and brand assets may support differentiation in a competitive landscape.
Vynleads operates in a highly competitive market with many larger and better-funded competitors, which may limit its ability to acquire and retain users cost-effectively. The transition from discrete products to a subscription platform involves operational and execution risks, including user engagement, retention, and monetization challenges. The company's limited liquidity and current net losses highlight financial constraints. Regulatory scrutiny related to wellness claims, AI use, and data privacy could impose additional compliance burdens. The reliance on third-party providers and a small employee base may affect operational resilience.
Vynleads' moat is centered on its proprietary AI-enabled wellness platform combining structured lifestyle programs with personalized coaching and community engagement. The integration of agentic AI workflows designed to coordinate specialized AI agents for conversational coaching, knowledge retrieval, and engagement is a distinctive technological approach. The company's brand portfolio, including Done With Diabetes and Dr. Smith AI Coach, along with its Lifestyle Blueprint personalization engine, provides intellectual property protection. However, the company faces competition from larger, better-resourced digital health and wellness providers. Its moat depends on maintaining user engagement, personalization capabilities, and enterprise readiness in a rapidly evolving market.
• Transition Execution Risk: The shift to an app-based subscription and platform model is materially different from prior discrete product offerings and may not achieve desired user acquisition, retention, or operating leverage [S1].
• User Engagement and Retention: Sustained user engagement and perceived relevance are critical; failure to maintain these could adversely affect growth and brand perception [S1].
• Competitive Pressure: The company faces competition from digital health apps, coaching programs, and enterprise wellness vendors with greater resources [S1].
• Regulatory and Compliance Risks: Operations are subject to evolving laws on consumer protection, advertising, privacy, AI governance, and digital wellness claims, which could lead to scrutiny or restrictions [S1].
• Financial and Liquidity Constraints: As of June 30, 2026, the company reported no revenue, a net loss, and low liquidity ratios, indicating financial constraints that may impact operations and growth [S2].
• Operational Dependence on Third Parties: With only one employee, the company relies heavily on third-party service providers and consultants, which may affect operational control and continuity [S1].
Business trends: Transitioning from discrete wellness products to a scalable, AI-enabled subscription platform targeting metabolic health and enterprise customers.
Execution milestones: Scaling the Done With Diabetes app, enhancing AI and agentic workflows, expanding enterprise distribution, and maintaining user engagement.
Key risks: Execution of platform transition, user retention, competitive pressures, regulatory compliance, financial constraints, and operational reliance on third parties.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Vynleads, Inc. is a Delaware corporation formed in July 2015 focused on wellness technology for metabolic health and chronic lifestyle-influenced conditions [S1].
- The flagship product is the Done With Diabetes app, an eight-week structured lifestyle-first wellness program for adults with type 2 diabetes, prediabetes, and related metabolic health goals [S1].
- The Done With Diabetes program is delivered via a digital platform with a proprietary Lifestyle Blueprint personalization engine, Dr. Smith AI Coach, and an emerging agentic AI support architecture [S1].
- The program is subscription-based, priced at $29 per month after a seven-day free trial, emphasizing recurring digital revenue [S1].
- The app guides users through a 56-day Success Blueprint with four phases: Foundation, Meal Plan, Lifestyle, and Control, combining education, habit formation, and accountability [S1].
- Users complete onboarding capturing lifestyle profile, goals, and baseline inputs, which personalize daily missions, educational content, meal guidance, recipes, check-ins, dashboards, and coaching prompts [S1].
- The AI support layer retrieves program knowledge, lesson content, recipes, exercises, motivational messages, and contextual content based on user progress and activity [S1].
- After the initial program, users enter Lifetime Wellness Mode for maintenance, relapse prevention, and ongoing engagement [S1].
- The company is transitioning from discrete digital wellness products to a scalable, recurring platform model with AI-enabled and agentic workflows to improve personalization and scalability [S1].
- Vynleads aims to expand beyond direct-to-consumer subscriptions to enterprise distribution through self-insured employers, health plans, payers, provider groups, and pharmacy benefit managers, with potential recurring revenue arrangements [S1].
- The company competes in a highly competitive market with digital health and wellness apps, coaching programs, and enterprise wellness vendors, many with greater resources [S1].
- The platform architecture is cloud-based, managing user accounts, program enrollment, daily missions, AI chat sessions, progress tracking, subscriptions, and administrative reporting [S1].
- The company relies on trademarks, copyrights, trade secrets, and proprietary technology including the Vynleads, Done With Diabetes, Lifestyle Blueprint, and Dr. Smith AI Coach brands [S1].
- Operations are subject to various laws and regulations including consumer protection, advertising, privacy, data security, AI governance, and online commerce [S1].
- As of March 24, 2026, Vynleads had one employee, the CEO, relying heavily on third-party service providers and consultants [S1].
- Financial snapshot as of June 30, 2026: cash and equivalents of $18,189; current assets $27,270; current liabilities $475,546; revenue $0; net loss $63,889; basic and diluted EPS $0; current ratio 0.06; cash ratio 0.04 [S2].
- The company reported no revenue and a net loss for the quarter ended June 30, 2026, indicating ongoing investment in platform development and operations [S2].
- Recent business news includes the launch of the Done With Diabetes app bringing AI-powered daily lifestyle support to blood sugar and metabolic health, and unveiling the broader Done With Lifestyle Blueprint technology platform [N1][N2].
Generated 2026-08-16
- S1 | 2026-03-31 | 10-K
- S2 | 2026-08-14 | 10-Q
- N1 | 2026-08-16 | www.nasdaq.com | Cattle Face Losses on Friday | https://www.nasdaq.com/articles/cattle-face-losses-friday
- N2 | 2026-08-16 | www.nasdaq.com | Dollar Falls on Weak US Retail Sales and Consumer Sentiment Reports | https://www.nasdaq.com/articles/dollar-falls-weak-us-retail-sales-and-consumer-sentiment-reports-0
- N3 | 2026-06-16 | www.nasdaq.com | Coffee Prices Surge as Rain Delays Brazil Harvest | https://www.nasdaq.com/articles/coffee-prices-surge-rain-delays-brazil-harvest
- N4 | 2026-06-16 | www.nasdaq.com | Sugar Prices Jump on Slack Monsoon Rain in India | https://www.nasdaq.com/articles/sugar-prices-jump-slack-monsoon-rain-india
- N5 | 2026-06-16 | www.nasdaq.com | Stocks Supported by Lower Crude Oil Prices and Bond Yields | https://www.nasdaq.com/articles/stocks-supported-lower-crude-oil-prices-and-bond-yields
- N6 | 2026-06-16 | www.nasdaq.com | Stock Market Today, June 16: Netflix Falls After Missing Out on Another Media Acquisition | https://www.nasdaq.com/articles/stock-market-today-june-16-netflix-falls-after-missing-out-another-media-acquisition
- N7 | 2026-06-16 | www.nasdaq.com | Stock Market Today, June 16: Snap Falls After Launch of $2,195 AR Glasses | https://www.nasdaq.com/articles/stock-market-today-june-16-snap-falls-after-launch-2195-ar-glasses
- N8 | 2026-06-16 | www.nasdaq.com | Billionaire Ken Griffin Sold Amazon and Nvidia but Quietly Loaded Up on This Healthcare Giant | https://www.nasdaq.com/articles/billionaire-ken-griffin-sold-amazon-and-nvidia-quietly-loaded-healthcare-giant
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


